Anti-prostate cancer and anti-EGFR activities of new Nilutamide-isoxazole hybrids. Chem Biol Lett. 2023;10(3):542. Accessed May 8, 2024. https://pubs.thesciencein.org/journal/index.php/cbl/article/view/a542